The Journal of Organic Chemistry
Article
(s). HRMS (ESI, positive) m/z calcd for C24H37N2O+: 369.2900,
found 369.2898.
Hz, 8 H, Har). 13C NMR (75 MHz, CDCl3): δ 40.9 (q), 70.2 (d,
Ar2CH), 112.6 (d), 129.6 (d), 130.6 (s), 149.6 (s).
N′-(Bis(4-(dimethylamino)phenyl)methyl)-formohydrazide (19).
A solution of (dma)2CH+BF4− (16i, 50 mg, 0.15 mmol) in acetonitrile
(5 mL) was added to a solution of formohydrazide (6, 9.0 mg, 0.15
mmol) in acetonitrile (5 mL) at rt. Then trimethylamine (0.1 mL, 33%
in ethanol) was added, and volatile compounds were evaporated under
reduced pressure after 5 min stirring at rt. The residue was dissolved in
N-(Bis(4-(dimethylamino)phenyl)methyl)-N-methylhydroxyl-
amine (24). Trimethylamine (15, 0.3 mL 33% in ethanol, 0.08 g, 1
mmol) was added to N-methylhydroxylamine hydrochloride (11·HCl,
60 mg, 0.72 mmol) at rt. A solution of (dma)2CH+BF4− (16i, 100 mg,
0.294 mmol) in acetonitrile (5 mL) was added dropwise over 5 min.
The 2 M NaOH (10 mL) was added, and the solution was extracted
with diethyl ether (15 mL). The ethereal phase was dried (Na2SO4)
and filtered, and the volatile compounds were evaporated under
reduced pressure: 24 (67 mg, 0.22 mmol, 76%), colorless oil. 1H NMR
(400 MHz, CDCl3): δ 2.56 (s, 3 H, N(OH)(CH3)), 2.87 (s, 12 H,
N(CH3)2), 4.43 (s, 1 H, Ar2CH), 5.16 (s br, 1 H, OH), 6.65 (d, J = 8.8
Hz, 4 H, Har), 7.28 (d, J = 8.7 Hz, 4 H, Har). 13C NMR (100 MHz,
CDCl3): δ 40.8 (q), 46.2 (q), 79.0 (d, Ar2CH), 112.8 (d), 128.5 (d),
130.8 (s), 149.8 (s). HRMS (EI, positive) m/z calcd for C18H25N3O+:
299.1998, found 299.2006.
1
CDCl3 and filtered. According to the H NMR, the product 19 was
formed exclusively as a 2:1 mixture of the (Z)- and (E)-isomers.35 1H
NMR (400 MHz, CDCl3): δ 2.91 (s, 12 H, CH3 Z), 2.92 (s, 12 H,
CH3 E), 4.14 (d, J = 5.6 Hz, 1 H, NHCH E), 4.81 (d, J = 5.0 Hz, 1 H,
Ar2CH E), 5.09 (s, 1 H, Ar2CH Z), 6.67−6.69 (m, 9 H, 4 × Har, Z, 4 ×
Har E, NHCHO E superimposed), 6.97 (s, 1 H, NHCHO Z), 7.17 (d,
J = 8.8 Hz, 4 H, Har E), 7.28 (d, J = 8.6 Hz, 4 H, Har Z), 8.00 (s, 1 H,
CHO Z), 8.26 (d, J = 10.9 Hz, 1 H, CHO E). 13C NMR (100 MHz,
CDCl3): δ 40.7 (q, N(CH3)2 E), 40.8 (q, N(CH3)2 Z), 67.6 (d, Ar2CH
E), 69.1 (d, Ar2CH Z), 112.8 (d, ArH Z and E superimposed), 128.1
(s, qAr E), 128.5 (d, ArH Z), 128.5 (d, ArH Z), 129.5 (s, qAr E), 150.1
(s, qAr Z), 150.2 (s, qAr E), 160.0 (d, CHO Z), 166.9 (d, CHO E).
HRMS (ESI, negative) m/z calcd for C18H23N4O−: 311.1877, found
311.1881.
N-(Bis(1,2,3,5,6,7-hexahydropyrido(3,2,1-ij)quinolin-9-yl)methyl)-
hydroxylamine (25). Trimethylamine (15, 0.5 mL 33% in ethanol, 0.1
mg, 2 mmol) was added to hydroxylamine hydrochloride (10·HCl, 7.8
mg, 0.11 mmol) at rt. A solution of (jul)2CH+BF4− (16e, 50 mg, 0.11
mmol) in acetonitrile (5 mL) was added dropwise at rt. The solution
was concentrated under reduced pressure, diethyl ether (5 mL) was
added, the precipitate was filtered off, and volatile compounds were
evaporated under reduced pressure: 25 (41 mg, 0.11 mmol, quant.),
colorless oil. 1H NMR (400 MHz, d6-DMSO): δ 1.24 (s br, 1 H, NH),
1.80−1.86 (m, 8 H, CH2CH2CH2), 2.61 (t, J = 6.5 Hz, 8 H,
CH2CH2CH2N), 3.02 (t, J = 5.5 Hz, 8 H, CH2CH2CH2N), 4.57 (s, 1
H, Ar2CH), 6.64 (s, 4 H, HAr), 7.15 (s br, OH). 13C NMR (100 MHz,
d6-DMSO): δ 21.8 (t), 27.2 (t), 49.4 (t), 69.4 (d, Ar2CH), 120.4 (s),
125.8 (d), 130.0 (s), 141.4 (s). HR-MS (ESI, positive) m/z calcd for
tert-Butyl 2-(bis(4-(dimethylamino)phenyl)methyl)-hydrazinecar-
boxylate (20). tert-Butyl hydrazinecarboxylate (8, 39 mg, 0.30 mmol)
−
was added to a solution of (dma)2CH+BF4 (16i, 100 mg, 0.294
mmol) in acetonitrile (5 mL) and stirred for 5 min at rt. Then 2 M
NaOH (10 mL) was added, and the solution was extracted with
diethyl ether (15 mL). The ethereal phase was dried (Na2SO4) and
filtered, and the volatile compounds were evaporated under reduced
1
pressure: 20 (113 mg, 0.294 mmol, quantitative), colorless oil. H
NMR (400 MHz, CDCl3): δ 1.42 (s, 9 H, C(CH3)3), 2.88 (s, 12 H,
N(CH3)2), 4.30 (s br, 1 H, NH), 5.11 (s, 1 H, Ar2CH), 6.09 (s br, 1 H,
+
C25H29N2 [M − NHOH]+: 357.2325, found 357.2325.
NH), 6.66 (d, J = 8.9 Hz, 4 H, Har), 7.25 (d, J = 8.7 Hz, 4 H, Har). 13
C
Bis(bis(4-(dimethylamino)phenyl)methyl)-amine (27). A solution
−
of (dma)2CH+BF4 (16i, 100 mg, 0.294 mmol) in acetonitrile (10
NMR (100 MHz, CDCl3): δ 28.5 (q), 40.8 (q), 67.2 (d, Ar2CH), 80.2
mL) was added to a solution of ammonia (12, 10 mL, 0.54 M, 5.4
mmol) in acetonitrile over 30 min at rt. After diethyl ether (20 mL)
was added, the solution was washed with 2 M NaOH (25 mL), dried
(Na2SO4), and filtered, and the solvent was evaporated under reduced
pressure: 27 (75 mg, 0.14 mmol, 98%), colorless crystals; mp 191−
192 °C (pentane), lit.24 mp 188 °C (benzene, ethanol). 1H NMR (300
MHz, CDCl3): δ 1.62 (s br, 1 H, NH), 2.91 (s, 24 H, N(CH3)2), 4.61
(s, 2 H, Ar2CH), 6.68 (d, J = 8.8 Hz, 8 H, Har), 7.22 (d, J = 8.7 Hz, 8
H, Har). 13C NMR (75 MHz, CDCl3): δ 41.0 (q), 62.2 (d, Ar2CH),
112.8 (d), 128.4 (d), 133.5 (s), 149.6 (s). HRMS (EI, positive) m/z
(s), 112.7 (d), 128.6 (d), 130.2 (s), 149.9 (s), 156.7 (s). HRMS (EI,
positive) m/z calcd for C22H32N4O2 : 384.2520, found 384.2512.
+
N′-(Bis(4-(dimethylamino)phenyl)methyl)-benzohydrazide (21).
Benzohydrazide (9, 60 mg, 0.44 mmol) was added to a solution of
−
(dma)2CH+BF4 (16i, 150 mg, 0.441 mmol) in acetonitrile (5 mL)
over 5 min at rt. Then 2 M NaOH (5 mL) was added, the solution was
extracted with diethyl ether (15 mL), and the ethereal phase was dried
(Na2SO4) and filtered. The solvent was partially evaporated under
reduced pressure, and the residue was cooled to −60 °C to crystallize
the product: 21 (161 mg, 0.41 mmol, 93%), colorless crystals; mp
143−144 °C (Et2O). 1H NMR (300 MHz, CD3CN): δ 2.88 (s, 12 H,
CH3), 5.10 (s br, 2 H, Ar2CH, NH), 6.71 (d, J = 8.9 Hz, 4 H, Har),
7.28 (d, J = 8.8 Hz, 4 H, Har), 7.38−7.42 (m, 2 H, Har), 7.46−7.53 (m,
1 H, Har), 7.61−7.66 (m, 2 H, Har), 8.36 (d br, J = 6.4 Hz, 1 H, NH).
13C NMR (75 MHz, CD3CN): δ 40.9 (q), 68.3 (d, Ar2CH), 113.5 (d),
+
calcd for C34H43N5 : 521.3518, found 521.3513.
(Bis(4-(dimethylamino)phenyl)methyl)-methylamine (28). Meth-
ylamine (13, 1 mL, 33% in ethanol, 0.2 g, 8 mmol) was added to a
solution of (dma)2CH+BF4− (16i, 100 mg, 0.294 mmol) in acetonitrile
(10 mL) and stirred for 5 min at rt. Then 2 M NaOH (10 mL) was
added, and the solution was extracted with diethyl ether (15 mL). The
ethereal phase was dried (MgSO4) and filtered, and the volatile
compounds were evaporated under reduced pressure: 28 (82 mg, 0.29
128.0 (d), 129.3 (d), 129.5 (d), 131.6 (s), 132.5 (d), 134.5 (s), 151.2
(s), 167.9 (s). HRMS (ESI, negative) m/z calcd for C24H27N4O−:
387.2190, found 387.2190.
1
mmol, 98%), colorless crystals; mp 125−126 °C (pentane). H NMR
N′-(Bis(4-(dimethylamino)phenyl)methyl)-hydroxylamine (22)
and N,N-(Bis-(bis(4-(dimethylamino)phenyl)methyl))-hydroxyl-
amine (23). Trimethylamine (15, 0.5 mL 33% in ethanol, 0.1 mg, 2
mmol) was added to hydroxylamine hydrochloride (10·HCl, 85 mg,
1.2 mmol) at rt, and acetonitrile (10 mL) was added. A solution of
(dma)2CH+BF4− (16i, 75 mg, 0.22 mmol) in acetonitrile (10 mL) was
added dropwise at rt. The solution was concentrated under reduced
pressure, diethyl ether (5 mL) was added, the precipitate was filtered
off, and volatile compounds were evaporated under reduced pressure.
According to the 1H NMR spectrum of the crude product, a 9:1
mixture of 22 and 23 was obtained. 22: 1H NMR (300 MHz, CDCl3):
δ 2.89 (s, 12 H, CH3), 5.05 (s, 1 H, Ar2CH), 5.53 (br s, 2 H, NH and
OH superimposed), 6.68 (d, J = 8.7 Hz, 4 H, Har), 7.22 (d, J = 8.8 Hz,
4 H, Har). 13C NMR (75 MHz, CDCl3): δ 40.8 (q), 69.6 (d, Ar2CH),
112.8 (d), 128.6 (d), 129 (s), 150.0 (s). HRMS (EI, positive) m/z
(300 MHz, CDCl3): δ 2.39 (s, 3 H, NH(CH3)), 2.90 (s, 12 H,
N(CH3)2), 4.54 (s, 1 H, Ar2CH), 6.68 (d, J = 8.8 Hz, 4 H, Har), 7.23
(d, J = 8.7 Hz, 4 H, Har). 13C NMR (75 MHz, CDCl3): δ 35.2 (q),
40.9 (q), 68.4 (d, Ar2CH), 112.9 (d), 128.0 (d), 132.9 (s), 149.7 (s).
+
HRMS (EI, positive) m/z calcd for C18H25N3 : 283.2048, found
283.2038.
(Bis(4-(dimethylamino)phenyl)methyl)-dimethylamine (29). Di-
methylamine (14, 0.5 mL 40% in water, 0.2 g, 4 mmol) was added to a
solution of (dma)2CH+BF4− (16i, 100 mg, 0.294 mmol) in acetonitrile
(10 mL) and stirred for 5 min at rt. Then 2 M NaOH (10 mL) was
added, and the solution was extracted with diethyl ether (15 mL). The
ethereal phase was dried (Na2SO4) and filtered, and the volatile
compounds were evaporated under reduced pressure: 29 (89 mg, 0.30
mmol, quantitative), pale yellow crystals; mp 92−93 °C (hexane), lit.36
mp 94 °C. 1H NMR (300 MHz, CDCl3): δ 2.19 (s, 6 H,
Ar2CHN(CH3)2), 2.88 (s, 12 H, N(CH3)2), 3.91 (s, 1 H, Ar2CH),
6.65 (d, J = 8.8 Hz, 4 H, Har), 7.25 (d, J = 8.9 Hz, 4 H, Har). 13C NMR
1
calcd (C17H24N3O+) 286.1914, found 286.1914. 23: H NMR (300
MHz, CDCl3): δ 2.89 (s, 24 H, CH3), 4.81 (s, 2 H, Ar2CH), 5.53 (br s,
1 H, OH superimposed by 22), 6.68 (d, 8.7, 8 H, Har), 7.29 (d, J = 8.7
8153
dx.doi.org/10.1021/jo301497g | J. Org. Chem. 2012, 77, 8142−8155